Patient Opportunity Trust Class FI (LMOFX)
| Fund Assets | 1.58B |
| Expense Ratio | 1.82% |
| Min. Investment | $1,000 |
| Turnover | 31.00% |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Dividend Growth | n/a |
| Payout Frequency | n/a |
| Ex-Dividend Date | n/a |
| Previous Close | 43.50 |
| YTD Return | 10.20% |
| 1-Year Return | 19.90% |
| 5-Year Return | 71.69% |
| 52-Week Low | 30.31 |
| 52-Week High | 44.46 |
| Beta (5Y) | n/a |
| Holdings | 44 |
| Inception Date | Feb 13, 2004 |
About LMOFX
Patient Opportunity Trust Class FI is an actively managed mutual fund focused on long-term capital growth through a value-oriented, contrarian investment approach. Managed by Patient Capital Management, the fund seeks to identify and invest in 30 to 50 companies that are believed to be significantly undervalued across various industries, sectors, and market capitalizations. Its strategy emphasizes flexibility, allowing investment in both domestic and select foreign equities, with approximately 87% of assets allocated to U.S. stocks and around 10% in foreign holdings. The fund distinguishes itself with a high active share—typically above 95%—making it a potential diversifier in a broad equity portfolio and offering differentiation from the S&P 500 benchmark. Led by an experienced management team, including Samantha McLemore, CFA, the fund’s concentrated portfolio and willingness to depart from mainstream investment trends can result in above-average volatility, but also offers the potential for significant long-term outperformance through market cycles. Since its inception in 2004, Patient Opportunity Trust Class FI has aimed to deliver disciplined, opportunistic value investing for investors seeking an alternative to conventional equity funds.
Performance
LMOFX had a total return of 19.90% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.13%.
Equivalent Funds
These are funds that follow the same index from the other major fund companies.
| Symbol | Provider | Name | Expense Ratio |
|---|---|---|---|
| FIQCX | Fidelity | Fidelity Advisor Asset Manager 85% - Class Z | 0.57% |
| FBRNX | Fidelity | Fidelity Advisor Stock Selector Fund - Class I | 0.48% |
| FSSKX | Fidelity | Fidelity Stock Selector Fund - Class K | 0.36% |
| FSJHX | Fidelity | Fidelity Advisor Stock Selector Fund - Class M | 0.98% |
| FEYAX | Fidelity | Fidelity Advisor Asset Manager 85% - Class A | 0.94% |
Top 10 Holdings
46.71% of assets| Name | Symbol | Weight |
|---|---|---|
| QXO, Inc. | QXO | 6.22% |
| Amazon.com, Inc. | AMZN | 5.57% |
| Citigroup Inc. | C | 5.04% |
| Alphabet Inc. | GOOGL | 4.83% |
| Meta Platforms, Inc. | META | 4.77% |
| Royalty Pharma plc | RPRX | 4.68% |
| NVIDIA Corporation | NVDA | 4.56% |
| Norwegian Cruise Line Holdings Ltd. | NCLH | 4.10% |
| CVS Health Corporation | CVS | 3.68% |
| Energy Transfer LP | ET | 3.25% |